Opioid analgesia for acute low back pain and neck pain (the OPAL trial): a randomised placebo-controlled trial
Caitlin Jones(Zhejiang University-University of Edinburgh Institute), Ven Tan, Stephanie Mathieson(The University of Sydney), Christopher Needs, Paul J. Wrigley, Laurent Billot(The George Institute for Global Health), Christopher G. Maher(The University of Sydney), Paul Preisz, Paul Schnitzler(Heidelberg University), Bart W. Koes(University of Southern Denmark), Christopher Davis(California University of Pennsylvania), Diana Merhi, Joseph Emmanuel, Séverine Bompoint(Royal North Shore Hospital), Melissa Webb, Nicholas A. Buckley(The University of Sydney), Andrew J. McLachlan(The University of Sydney), Bridin Murnion, Sabine Fieuw‐Makaroff, Chung‐Wei Christine Lin(The University of Sydney), Lucia Genua, Richard O. Day(St Vincent's Hospital Sydney), Hanan McLachlan(The University of Sydney), Adam Gaudry, Sabiha Shahnaz, I. C. Longhurst, Jane Latimer(The University of Sydney), Melanie Hamilton(George Washington University), Wendy Mak, Harbeer Ahedi, Michael Burke(Tel Aviv University), Apo Demirkol, Samuel Cantori, Francisco Javier Valencia Cepeda, Jayasree Dullur, Catherine Errey, Kenneth McCroary, Zahra Rassoly Obayd, Michelle Penm, Sharan Pobbathi, Angie Barber, Greg Cameron, Sujata Allan, Louise Brooks, William S Poh, Veronika Petrova, Sana Shan(UNSW Sydney), James Aitken, Tanya T. Nguyen(University of California San Diego)
Cited by 165
Related Papers
Intensive Blood Glucose Control and Vascular Outcomes in Patients with Type 2 Diabetes
|New England Journal of Medicine|2008|7.4k
Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy
|New England Journal of Medicine|2019|6k
What low back pain is and why we need to pay attention
|The Lancet|2018|4.7k
Prevention and treatment of low back pain: evidence, challenges, and promising directions
|The Lancet|2018|2.5k
Clinical practice guidelines for the management of non-specific low back pain in primary care: an updated overview
|European Spine Journal|2018|1.6k